Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 11.662\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COC(=O)c1cc(NC(=O)c2ccc(-c3ccccc3)cc2)ccc1Cl
b.) Cc1ccc(C)c(/C(O)=C2\C(=O)C(=O)N(CCCn3ccnc3)C2c2ccncc2)c1
c.) c1ccc(-c2csc3ncnc(NCC4COc5ccccc5O4)c23)cc1
d.) CC1CC(C)(C)NCCNC(C)CC(C)(C)NCCN1
e.) CCOC(=O)C1=NN(c2ccccc2)C(=O)/C1=C\c1ccc(N(C)C)cc1
Answer: c. c1ccc(-c2csc3ncnc(NCC4COc5ccccc5O4)c23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(-c2csc3ncnc(NCC4COc5ccccc5O4)c23)cc1
c1ccc(-c2csc3ncnc(NCC4COc5ccccc5O4)c23)cc1
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-5-phenylthieno[2,3-d]pyrimidin-4-amine